Vor Bio (VOR) announced that results from a Phase 3 study in China evaluating telitacicept in systemic lupus erythematosus, SLE, sponsored by its collaborator, RemeGen, were published in The New ...

ClickFix attacks have evolved to feature videos that guide victims through the self-infection process, a timer to pressure targets into taking risky actions, and automatic detection of the operating ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The latest price target for Vor Biopharma (NASDAQ:VOR) was reported by HC Wainwright & Co. on October 29, 2025. The analyst firm set a price target for $52.00 expecting VOR to rise to within 12 months ...

The challenges facing biotechs amid the ongoing financial fallout have resulted in the winding down of one US biotech, Vor Bio, and job losses at a clutch of other firms. Cambridge, ...

Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated at ...

A resource for reactor physicists and engineers and students of nuclear power engineering, this publication provides a comprehensive summary of the thermophysical properties data needed in nuclear ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...

The advent of the sixth-generation (6G) networks presents another round of revolution for the mobile communication landscape, promising an immersive experience, robust reliability, minimal latency, ...

Abstract: Intelligent reflecting surface (IRS) is an enabling technology to engineer the radio signal propagation in wireless networks. By smartly tuning the signal reflection via a large number of ...